Novel insights into lipid antigen presentation

Trends in Immunology

Volumn 33, Issue 3, 2012, Pages 103-111

  De Libero, Gennaro ^a,b   Mori, Lucia ^a,b  

^a AGENCY FOR SCIENCE   (Singapore)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD1 ANTIGEN; CD1B ANTIGEN; CD1C ANTIGEN; CD1D ANTIGEN; CD1E ANTIGEN; LIPID ANTIGEN; LYMPHOCYTE ANTIGEN; PHOSPHOLIPID; SPHINGOLIPID; T6 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; GENE EXPRESSION; HUMAN; IMMUNE EVASION; IMMUNITY; INTRACELLULAR TRANSPORT; LIPID ANTIGEN PRESENTATION; LYSOSOME; MOLECULAR MECHANICS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; GENE EXPRESSION REGULATION; HUMANS; LIPIDS; PROTEIN TRANSPORT;

EID: 84857684717     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.01.005     Document Type: Review

References (74)

1. Dascher C.C., Brenner M.B. Evolutionary constraints on CD1 structure: insights from comparative genomic analysis. Trends Immunol. 2003, 24:412-418.
2. van den Elzen P., et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 2005, 437:906-910.
3. Wang S.H., et al. High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy. Clin. Exp. Immunol. 2010, 160:137-142.
4. Zhang H.L., et al. The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Dev. Immunol. 2010, 2010:186813.
5. Freigang S., et al. Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice. J. Clin. Invest. 2010, 120:1873-1884.
6. Allan L.L., et al. Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells. Blood 2009, 114:2411-2416.
7. Tupin E., et al. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 2007, 5:405-417.
8. Kang S.J., Cresswell P. Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J. Biol. Chem. 2002, 277:44838-44844.
9. Brutkiewicz R.R., et al. TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1. J. Exp. Med. 1995, 182:1913-1919.
10. Balk S.P., et al. Beta 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science 1994, 265:259-262.
11. Giabbai B., et al. Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation. J. Immunol. 2005, 175:977-984.
12. Garcia-Alles L.F., et al. Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. EMBO J. 2006, 25:3684-3692.
13. Cox D., et al. Determination of cellular lipids bound to human CD1d molecules. PLoS ONE 2009, 4:e5325.
14. Yuan W., et al. Natural lipid ligands associated with human CD1d targeted to different subcellular compartments. J. Immunol. 2009, 182:4784-4791.
15. Haig N.A., et al. Identification of self-lipids presented by CD1c and CD1d proteins. J. Biol. Chem. 2011, 286:37692-37701.
16. Garcia-Alles L.F., et al. Structural reorganization of the antigen-binding groove of human CD1b for presentation of mycobacterial sulfoglycolipids. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:17755-17760.
17. Brennan P.J., et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat. Immunol. 2011, 12:1202-1211.
18. Jayawardena-Wolf J., et al. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 2001, 15:897-908.
19. Kang S.J., Cresswell P. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J. 2002, 21:1650-1660.
20. Briken V., et al. Intracellular trafficking pathway of newly synthesized CD1b molecules. EMBO J. 2002, 21:825-834.
21. Sloma I., et al. Regulation of CD1a surface expression and antigen presentation by invariant chain and lipid rafts. J. Immunol. 2008, 180:980-987.
22. Barral D.C., Brenner M.B. CD1 antigen presentation: how it works. Nat. Rev. Immunol. 2007, 7:929-941.
23. Barral D.C., et al. CD1a and MHC class I follow a similar endocytic recycling pathway. Traffic 2008, 9:1446-1457.
24. Garg S., et al. Lysosomal trafficking, antigen presentation, and microbial killing are controlled by the Arf-like GTPase Arl8b. Immunity 2011, 35:182-193.
25. Im J.S., et al. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity 2009, 30:888-898.
26. Prigozy T.I., et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 2001, 291:664-667.
27. de la Salle H., et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 2005, 310:1321-1324.
28. Darmoise A., et al. Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells. Immunity 2010, 33:216-228.
29. Riese R.J., et al. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. Immunity 2001, 15:909-919.
30. Honey K., et al. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat. Immunol. 2002, 3:1069-1074.
31. Nakken B., et al. Peroxisome proliferator-activated receptor gamma-regulated cathepsin D is required for lipid antigen presentation by dendritic cells. J. Immunol. 2011, 187:240-247.
32. Van Rhijn I., et al. CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids. J. Exp. Med. 2009, 206:1409-1422.
33. Bai L., et al. Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:10254-10259.
34. Odyniec A.N., et al. Regulation of CD1 antigen-presenting complex stability. J. Biol. Chem. 2010, 285:11937-11947.
35. Cernadas M., et al. Early recycling compartment trafficking of CD1a is essential for its intersection and presentation of lipid antigens. J. Immunol. 2010, 184:1235-1241.
36. Muindi K., et al. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3052-3057.
37. Facciotti F., et al. Fine tuning by human CD1e of lipid-specific immune responses. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14228-14233.
38. Garcia-Alles L.F., et al. Crystal structure of human CD1e reveals a groove suited for lipid-exchange processes. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:13230-13235.
39. Zhou D., et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 2004, 303:523-527.
40. Winau F., et al. Saposin C is required for lipid presentation by human CD1b. Nat. Immunol. 2004, 5:169-174.
41. Schrantz N., et al. The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J. Exp. Med. 2007, 204:841-852.
42. Relloso M., et al. pH-dependent interdomain tethers of CD1b regulate its antigen capture. Immunity 2008, 28:774-786.
43. Moll M., et al. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 2010, 116:1876-1884.
44. Rao P., et al. Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function. J. Virol. 2011, 85:8093-8104.
45. Raftery M.J., et al. Inhibition of CD1 antigen presentation by human cytomegalovirus. J. Virol. 2008, 82:4308-4319.
46. Renukaradhya G.J., et al. Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway. J. Virol. 2008, 82:12535-12542.
47. Mariotti S., et al. Mycobacterium tuberculosis subverts the differentiation of human monocytes into dendritic cells. Eur. J. Immunol. 2002, 32:3050-3058.
48. Mariotti S., et al. Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells. Infect. Immun. 2004, 72:4385-4392.
49. Gagliardi M.C., et al. Cell wall-associated alpha-glucan is instrumental for Mycobacterium tuberculosis to block CD1 molecule expression and disable the function of dendritic cell derived from infected monocyte. Cell. Microbiol. 2007, 9:2081-2092.
50. Stenger S., et al. Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J. Immunol. 1998, 161:3582-3588.
51. Roura-Mir C., et al. Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2. J. Immunol. 2005, 175:1758-1766.
52. Schaible U.E., et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat. Med. 2003, 9:1039-1046.
53. Khan M.A., et al. Anthrax lethal toxin impairs CD1d-mediated antigen presentation by targeting the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway. Infect. Immun. 2010, 78:1859-1863.
54. Yakimchuk K., et al. Borrelia burgdorferi infection regulates CD1 expression in human cells and tissues via IL1-beta. Eur. J. Immunol. 2011, 41:694-705.
55. Li D., et al. Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interaction. J. Immunol. 2009, 182:1033-1040.
56. Manolova V., et al. Functional CD1a is stabilized by exogenous lipids. Eur. J. Immunol. 2006, 36:1083-1092.
57. Szatmari I., et al. Activation of PPARgamma specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. Immunity 2004, 21:95-106.
58. Gogolak P., et al. Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARgamma. Blood 2007, 109:643-652.
59. Leslie D.S., et al. Serum lipids regulate dendritic cell CD1 expression and function. Immunology 2008, 125:289-301.
60. Szanto A., et al. STAT6 transcription factor is a facilitator of the nuclear receptor PPARgamma-regulated gene expression in macrophages and dendritic cells. Immunity 2010, 33:699-712.
61. Almeida P.E., et al. Mycobacterium bovis bacillus Calmette-Guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. J. Immunol. 2009, 183:1337-1345.
62. Smed-Sorensen A., et al. IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa. Blood 2008, 111:5037-5046.
63. Nascimento C.R., et al. The short chain fatty acid sodium butyrate regulates the induction of CD1a in developing dendritic cells. Immunobiology 2011, 216:275-284.
64. Schumann J., et al. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. Eur. J. Immunol. 2007, 37:1431-1441.
65. Gadola S.D., et al. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 2006, 203:2293-2303.
66. Brozovic S., et al. CD1d function is regulated by microsomal triglyceride transfer protein. Nat. Med. 2004, 10:535-539.
67. Kaser A., et al. Microsomal triglyceride transfer protein regulates endogenous and exogenous antigen presentation by group 1 CD1 molecules. Eur. J. Immunol. 2008, 38:2351-2359.
68. Zeissig S., et al. Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. J. Clin. Invest. 2010, 120:2889-2899.
69. Sagiv Y., et al. A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d. J. Exp. Med. 2007, 204:921-928.
70. Angenieux C., et al. Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells. J. Biol. Chem. 2000, 275:37757-37764.
71. Angenieux C., et al. The cellular pathway of CD1e in immature and maturing dendritic cells. Traffic 2005, 6:286-302.
72. Maitre B., et al. The assembly of CD1e is controlled by an N-terminal propeptide which is processed in endosomal compartments. Biochem. J. 2009, 419:661-668.
73. Maitre B., et al. Control of the intracellular pathway of CD1e. Traffic 2008, 9:431-445.
74. Tourne S., et al. A naturally occurring mutation in CD1e impairs lipid antigen presentation. J. Immunol. 2008, 180:3642-3646.